Literature DB >> 19728407

Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).

D M Simpson, J-M Gracies, K Graham, M Hallett, J Miyasaki, M Naumann, B Russman, L Simpson, Y So.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19728407

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity.

Authors:  Khashayar Dashtipour; Jack J Chen; Heather W Walker; Michael Y Lee
Journal:  Am J Phys Med Rehabil       Date:  2015-03       Impact factor: 2.159

2.  Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.

Authors:  Edwin Vazquez-Cintron; Luis Tenezaca; Christopher Angeles; Aurelia Syngkon; Victoria Liublinska; Konstantin Ichtchenko; Philip Band
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

3.  Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke.

Authors:  Mohammad Nasb; Zhenlan Li; Ahmed S A Youssef; Lamis Dayoub; Hong Chen
Journal:  Libyan J Med       Date:  2019-12       Impact factor: 1.657

4.  Botulinum toxin injections as salvage therapy is beneficial for management of patellofemoral pain syndrome.

Authors:  Yuval Kesary; Vivek Singh; Tal Frenkel-Rutenberg; Arie Greenberg; Shmuel Dekel; Ran Schwarzkopf; Nimrod Snir
Journal:  Knee Surg Relat Res       Date:  2021-10-29

Review 5.  Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity.

Authors:  Khashayar Dashtipour; Jack J Chen; Heather W Walker; Michael Y Lee
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.